Passing of break-even milestone by MySQUAR prompts unexpected reaction
The Myanmar-language social media, entertainment and payments platform operator is breaking even at the current run-rate
Company
Futura Medical PLC
LON:FUM
Futura Medical specialises in the development and global commercialisation of innovative sexual health products, including lead product Eroxon®. The company's core strength lies in its research, development and commercialisation of topically delivered gel formulations in sexual health products.
303 stories · page 13 of 16
Futura Medical shares boosted by step-up in investor roadshows
The presentation gives a a detailed insight into key aspects of the clinical development and commercial potential of the product.
Archive
Proactive news round-up: Sound Energy, Gemfields, Sunrise Resources...
A glance at some of the stories on the Proactive Investors newswire today
Sunrise Resources radiating positivity over pozzolan
Risers and fallers: Advanced Oncotherapy, St Ives, Intelligent Energy
Futura Medical chairman says there is “significant commercial interest” in its erectile dysfunction drug
Last month the company received a boost in the form of “constructive feedback” from regulators in both the UK and US reviewing the clinical trial requirements for MED2002.
Archive
Proactive news round-up: Eurasia Mining, Gemfields, OPG Power Ventures...
Some of the small cap stories on the Proactive newswire today
Styles&Wood Group heads higher on chipper outlook
Some of the main risers and fallers in London at 3.40pm
Futura Medical shares up as firm "delighted" by regulator feedback on erectile dysfunction drug
Written responses from America’s Food & Drug Administration and the Medicines & Healthcare products Regulatory Agency (MHRA) here in Britain support its timeline, which sees marketing approval for the product in the second-quarter of 2019.
FTSE 100 closes lower as election worries dent sentiment
The FTSE 100 closed down 6.56, or 0.09% to 7,519...
Illika accelerates away on US battery patent
Main share price risers and fallers in London at 3.45pm: Ilika, Halma, Public Service Props
Futura Medical encouraged by high level of interest from potential licensing partners for its erectile dysfunction gel
The £12mln fund-raise in November left the company tooled-up to develop its breakthrough erectile dysfunction
FTSE 100 closes higher with retailer Next top riser
FTSE 100 was three points higher at 7,238, Next rises strongly.
Archive
Next to report first annual profit decline in eight years as Brexit hurts retailers
Next plc is facing the industry-wide pressure of rising inflation but its issues are also company-specific
Frontera Resources surges after investor conference
Some of the largest rises and fallers at 3pm: Frontera, Franchise Brands, Starcom
Futura Medical inks Portugal distribution deal for its condom line
The company is partnering with F Lima, which supplies consumer brands to supermarkets and pharmacies.
Archive
Next firmly on the back foot as shoppers batten down hatches
Week ahead: Next, Kingfisher, Smiths Group ,Satellite Solutions ...
Urals Energy jumps on plans for Russian assets
Some of the largest rises and falls in London at 15:45pm: Urals Energy, Acacia Mining, Vela Technologies
Futura Medical has US$1bn plus product in MED2002 says new research
Ipsos predicts peak OTC or without prescription annual sales for MED2002 in excess of US$650mln